858 related articles for article (PubMed ID: 21611961)
1. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
[TBL] [Abstract][Full Text] [Related]
2. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
3. Identification and analysis of type II TGF-β receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells.
Wu N; Zhao Y; Yin Y; Zhang Y; Luo J
Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):699-708. PubMed ID: 20801928
[TBL] [Abstract][Full Text] [Related]
4. The role of noggin in human mesenchymal stem cell differentiation.
Rifas L
J Cell Biochem; 2007 Mar; 100(4):824-34. PubMed ID: 17133353
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells.
Figueroa JD; Hayman MJ
Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847
[TBL] [Abstract][Full Text] [Related]
6. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro.
Hiraki Y; Inoue H; Shigeno C; Sanma Y; Bentz H; Rosen DM; Asada A; Suzuki F
J Bone Miner Res; 1991 Dec; 6(12):1373-85. PubMed ID: 1665281
[TBL] [Abstract][Full Text] [Related]
8. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells.
de Jong DS; Steegenga WT; Hendriks JM; van Zoelen EJ; Olijve W; Dechering KJ
Biochem Biophys Res Commun; 2004 Jul; 320(1):100-7. PubMed ID: 15207708
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
13. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
14. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
15. Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2.
Yuasa T; Kataoka H; Kinto N; Iwamoto M; Enomoto-Iwamoto M; Iemura S; Ueno N; Shibata Y; Kurosawa H; Yamaguchi A
J Cell Physiol; 2002 Nov; 193(2):225-32. PubMed ID: 12385000
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.
de Jong DS; van Zoelen EJ; Bauerschmidt S; Olijve W; Steegenga WT
J Bone Miner Res; 2002 Dec; 17(12):2119-29. PubMed ID: 12469906
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells.
Mikami Y; Asano M; Honda MJ; Takagi M
J Cell Physiol; 2010 Apr; 223(1):123-33. PubMed ID: 20039267
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
19. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.
Harris SE; Bonewald LF; Harris MA; Sabatini M; Dallas S; Feng JQ; Ghosh-Choudhury N; Wozney J; Mundy GR
J Bone Miner Res; 1994 Jun; 9(6):855-63. PubMed ID: 8079661
[TBL] [Abstract][Full Text] [Related]
20. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
